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Abstract
Allele-specific DNA methylation (ASM) is well studied in imprinted domains, but this type of epigenetic asymmetry is
actually found more commonly at non-imprinted loci, where the ASM is dictated not by parent-of-origin but instead by the
local haplotype. We identified loci with strong ASM in human tissues from methylation-sensitive SNP array data. Two index
regions (bisulfite PCR amplicons), one between the C3orf27 and RPN1 genes in chromosome band 3q21 and the other near
the VTRNA2-1 vault RNA in band 5q31, proved to be new examples of imprinted DMRs (maternal alleles methylated) while a
third, between STEAP3 and C2orf76 in chromosome band 2q14, showed non-imprinted haplotype-dependent ASM. Using
long-read bisulfite sequencing (bis-seq) in 8 human tissues we found that in all 3 domains the ASM is restricted to single
differentially methylated regions (DMRs), each less than 2kb. The ASM in the C3orf27-RPN1 intergenic region was placenta-
specific and associated with allele-specific expression of a long non-coding RNA. Strikingly, the discrete DMRs in all 3 regions
overlap with binding sites for the insulator protein CTCF, which we found selectively bound to the unmethylated allele of
the STEAP3-C2orf76 DMR. Methylation mapping in two additional genes with non-imprinted haplotype-dependent ASM,
ELK3 and CYP2A7, showed that the CYP2A7 DMR also overlaps a CTCF site. Thus, two features of imprinted domains, highly
localized DMRs and allele-specific insulator occupancy by CTCF, can also be found in chromosomal domains with non-
imprinted ASM. Arguing for biological importance, our analysis of published whole genome bis-seq data from hES cells
revealed multiple genome-wide association study (GWAS) peaks near CTCF binding sites with ASM.
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Introduction
Evidence from genome-wide association studies (GWAS) and
cross-species comparisons suggests that many inter-individual
phenotypic differences result from genetic variants in non-coding
DNA sequences. Thus a major challenge in the post-genomic era
is to define the mechanisms by which non-coding sequence
polymorphisms and haplotypes result in differences in biological
phenotypes. One hypothesis comes from recent work that has
revealed strong cis-acting influences of simple nucleotide polymor-
phisms (SNPs), and the haplotypes in which these SNPs are
embedded, on epigenetic marks, leading to allele-specific DNA
methylation (ASM) and allele-specific chromatin structure [1].
Historically, ASM has been most intensively studied in the context
of genomic imprinting - a parent-of-origin dependent phenome-
non that affects about 80 human genes. Mechanistic principles
that have emerged from studying imprinted domains include the
presence of discrete small (one to several kb) DNA intervals, called
differentially methylated regions (DMRs), which show strong
parent-of-origin dependent asymmetry in CpG methylation
between the two alleles and which control the allele-specific
expression (ASE) of one or more nearby genes in cis, in some cases
via methylation-sensitive binding of the insulator protein CTCF
[2–6].
While genomic imprinting is a potent mode of gene regulation,
it affects fewer loci than the more recently recognized phenom-
enon of non-imprinted haplotype-dependent ASM. Mapping
haplotype-dependent ASM, and related phenomena such as
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ASE, will be useful for interpreting the biological meaning of
statistical peaks from GWAS (and non-coding variants from post-
GWAS exome sequencing studies), as bona fide regulatory sequence
variants can reveal their presence by conferring a measurable
epigenetic asymmetry between the two alleles. However as yet
there have not been many insights to the molecular mechanisms
underlying non-imprinted ASM. This situation raises an interest-
ing question – could any principles from studies of genomic
imprinting also be relevant for understanding haplotype-depen-
dent, non-imprinted, ASM? To begin to address this issue, and to
identify and characterize new examples of loci with imprinted and
non-imprinted ASM, we have searched for ‘‘index regions’’ in the
human genome showing strong and highly recurrent ASM and
used these locations as starting points for intensive local mapping
of DNA methylation patterns in multiple human tissues. Here we
describe these data for new examples of loci with imprinted and
non-imprinted ASM, which reveal epigenomic features that are
shared between these two allele-specific phenomena.
Results
Index regions with ASM identified by MSNP
The MSNP procedure, an adaptation of SNP arrays for
detecting ASM, was described in our initial report of haplotype-
dependent ASM in human tissues [7]. As a starting point for
comparing the structures of chromosomal domains with imprinted
(parent-of-origin dependent) versus non-imprinted (haplotype
dependent) ASM we applied higher resolution MSNP to several
human tissue types from multiple individuals and identified 4
additional SNP-tagged StyI or NspI restriction fragments with CpG
dinucleotides in HpaII sites that showed strongly asymmetrical
methylation between the two alleles in multiple heterozygous
samples (examples in Figure S1). These index fragments are tagged
by SNPs rs1530562 between the STEAP3 and C2orf76 genes
(chromosome band 2q14), rs2346019 near the VTRNA2-1 vault
family small RNA gene (5q31.1), rs2811488 between the C3orf27
and RPN1 genes (3q21), and rs2302902 in the ELK3 gene
(12q23.1). We used Sanger bisulfite sequencing (bis-seq) of
amplicons containing these SNPs and multiple (non-polymorphic)
adjacent CpG dinucleotides to confirm ASM in heterozygous
individuals in a panel of primary tissues chosen for relevance to
complex diseases and representation of multiple cell lineages:
peripheral blood (PBL), whole fetal and adult lung and adult
bronchial epithelial cells, adult liver, adult brain (cerebral cortical
grey matter), placenta (chorionic villi taken from near the fetal
surface), human mammary epithelial cells (HMEC), and sperm.
These analyses showed that the ASM was reproducible for all 4
index fragments, with the allelic asymmetry in methylation
affecting multiple (non-polymorphic) CpGs around and including
the index HpaII sites (Fig. 1 and Figs. S2, S3, S4). Among these 4
regions, moderate ASM was observed in the ELK3 gene, while the
other index regions showed stronger allelic asymmetries. ASM was
seen in two or more tissues for each of the index regions except the
C3orf27-RPN1 region, for which the index amplicon revealed
highly tissue-specific ASM, which was very strong in the large
majority of human placentas examined (33/34 cases; all tested
using tissue from the fetal side of the organ, consisting of the free
chorionic villi without maternal decidua; Table 1), but absent in
the other tissues tested (Fig. 1, Table 1 and Figure S3).
ASM in the STEAP3-C2orf76 and ELK3 regions is non-
imprinted and haplotype dependent
We next asked whether the ASM in each of these 4 regions was
due to parental imprinting or, alternatively, to cis-acting effects of
the local DNA sequence or haplotype. Sanger and bis-seq in a
total of 198 and 129 individuals with all 3 possible genotypes, plus
HpaII-pre-digestion/PCR/RFLP assays [7] in 76 and 30 hetero-
zygotes, respectively, showed unequivocally that ASM both in the
STEAP3-C2orf76 intergenic region and in the ELK3 intragenic
region is haplotype-dependent: the simple genotypes at nearby
SNPs consistently predicted the methylation status of 10 and 6
clustered CpGs, respectively, in these two index amplicons (Fig. 1
and Table 1). The ASM at both loci showed some tissue-
specificity: for the STEAP3-C2orf76 intergenic amplicon we found
strong ASM in multiple tissues including brain, placenta, liver,
HMEC, and PBL; with sperm DNA showing biallelic hyper-
methylation, while for the ELK3 intergenic amplicon we found
strong ASM in PBL and weak ASM in liver, with HMEC DNA
showing biallelic hypermethylation (Fig. 1 and Table 1).
ASM in the VTRNA2-1 and C3orf27-RPN1 regions is due to
parental imprinting
In contrast to the results for the STEAP3-C2orf76 and ELK3
index regions, Sanger and bis-seq in 192 and 325 individuals with
all 3 possible genotypes and restriction pre-digestion/PCR/RFLP
assays in 70 and 75 heterozygotes for the C3orf27-RPN1 and
VTRNA2 index regions respectively showed that either allele could
be relatively hypermethylated with the genotype of the index SNP
having no predictive value - a situation suggestive of imprinting, in
which methylation is dictated by parent-of-origin, not by
haplotype (Table 1). To test for bona fide parental imprinting at
these two loci we analyzed trios of maternal and paternal PBL and
placenta DNA. In each of 13 trios informative for the C3orf27-
RPN1 index SNP and in each of 10 trios informative for the
VTRNA2-1 index SNP we found relative hypermethylation of the
maternal allele in the placental DNA (p= 0.000311 for parental
imprinting of the C3orf27-RPN1 locus and p= 0.001565 for the
VTRNA2 locus, Chi-Square test; Fig. 2). While this manuscript was
in preparation Treppendahl et al. reported ASM at VTRNA2-1 in
human hematopoietic cells [8] but imprinting was not tested in
that study. Imprinting has not been previously reported in the
Author Summary
Allele-specific DNA methylation (ASM) is a central mech-
anism of gene regulation in humans, which can influence
inter-individual differences in physical and mental traits
and disease susceptibility. ASM is mediated either by
parental imprinting, in which the repressed copy (allele) of
the gene is determined by which type of parent (mother or
father) transmitted it or, for a larger number of genes, by
the local DNA sequence, independent of which parent
transmitted it. Chromosomal regions with imprinted ASM
have been well studied, and certain mechanistic principles,
including the role of discrete differentially methylated
regions (DMRs) and involvement of the insulator protein
CTCF, have emerged. However, the molecular mechanisms
underlying non-imprinted sequence-dependent ASM are
not yet understood. Here we describe our detailed
mapping of ASM across 5 gene regions, including two
novel examples of imprinted ASM and three gene regions
with non-imprinted, sequence-dependent ASM. Our data
uncover shared molecular features – small discrete DMRs,
and the binding of CTCF to these DMRs, in examples of
both types of ASM. Combining ASM mapping with genetic
association data suggests that sequence-dependent ASM
at CTCF binding sites influences diverse human traits.
DMRs for Imprinted and Non-Imprinted ASM
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C3orf27-RPN1 region. As noted above, in the RPN1 downstream
DMR the ASM was restricted to placenta DNA samples, and in
both loci sperm DNA showed biallelic hypomethylation, suggest-
ing that the methylation imprint is acquired in the oocyte or early
post-zygotically. The parent-of-origin dependence of the ASM in
this region indicates that at least the initial ‘‘signal’’ for the imprint
must be gametic, not somatic. However, we do not yet know the
pattern of methylation in oocytes, so whether the densely
methylated pattern of the maternal allele is established in the
oocyte, or acquired early post-zygotically, remains to be deter-
mined.
By analogy with other imprinted genes [9,10], the placenta-
specific methylation imprinting of the RPN1 39 region could be
relevant to placental and fetal growth, so for planning future
studies it is relevant to ask whether imprinting of this region also
occurs in mice. The mouse genome shows conservation of synteny
with regard to the linkage and order of the Rab7-Rpn1-Gata2 genes,
but an orthologue of human C3orf27 (which is located between the
human RPN1 and GATA2 genes) is not present in this region of the
mouse genome. Moreover, the full-fledged CGI at the 39 end of
the RPN1 gene in humans is not present in this position of the
mouse Rpn1 gene. Despite this lack of conservation of the CGI,
and indeed the lack of conservation of the DNA sequence in this
region, we tested for ASM in a CG-rich sequence located
immediately downstream of Rpn1 in the mouse, in a position
analogous to the human DMR. Using extraembryonic tissues (yolk
sac and placenta) from reciprocal inter-strain mouse crosses we
found that CpG methylation in the orthologous region is
somewhat allele-specific, but with much less allelic asymmetry
than the human locus (Figure S5A). The methylation patterns in
the mouse yolk sac and placenta are most simply explained by
weak parental imprinting superimposed on a cis-acting haplotype
effect. After accounting for the cis-effect (CAST allele more
methylated than B6 allele), the direction of the weak imprinting
Figure 1. Bis-seq showing strong ASM in the ELK3, STEAP3-C2orf76, C3orf27-RPN1, and VTRNA2-1 index regions. A, Gene map and bis-seq
of the index amplicon containing SNP rs2302902 in the first intron of the ELK3 gene. The strong asymmetry in CpG methylation, with the G allele
consistently hypermethylated in the PBL samples, indicates haplotype-dependent non-imprinted ASM (additional data in Table 1; haplotype map in
Figure S5). There is some tissue-specificity, with biallelic hypermethylation in the HMEC sample. The grey (lower) bars indicate the index amplicons for
initial bis-seq, each tagged by the index SNP that showed recurrent ASM in the MSNP data. The green bars indicate CGIs and the black rectangles are
exons. The X’s indicate polymorphic CpG sites. B, Gene map and bis-seq of the index amplicon containing SNP rs1530562, between the STEAP3 and
C2orf76 genes in chromosome band 2q14, showing strong ASM with the G allele consistently hypermethylated in multiple tissues consistent with
haplotype-dependent non-imprinted ASM, but with biallelic hypermethylation in sperm DNA (additional data in Table 1). C, Gene map and bis-seq of
the index amplicon containing SNP rs2811488 located downstream of the last exon of the RPN1 gene in chromosome band 3q21, showing strong
ASM in placenta, with the G allele or A allele hypermethylated, depending on parent-of-origin, as proven in Figure 2. For this imprinted DMR the ASM
is highly tissue-specific, being seen in placenta but not in PBL, liver, lung, brain, HMEC or sperm (additional data in Table 1 and Figure S2). D, Gene
map and bilsufite sequencing of the index amplicon containing SNP rs2346019 downstream of the VTRNA2-1 vault-family RNA, located in
chromosome band 5q31. Strong ASM is observed in multiple tissues with the A allele or G allele methylated, consistent with imprinting, which is
proven by the data in Figure 2.
doi:10.1371/journal.pgen.1003622.g001
DMRs for Imprinted and Non-Imprinted ASM
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Table 1. Summary of the 5 DMRs characterized in this report.
Chromosome position














STEAP3 - C2orf76 0.45 kb YES PBL (20/29), liver (15/17),
placenta (7/8), lung (3/4),









C3orf27 - RPN1 1 kb YES PBL (0/12), liver (0/10),
placenta (33/34), lung (0/3),





VTRNA2-1 1.9 kb YES PBL (13/17), liver (17/17),
placenta (11/15), lung (5/6),
HMEC (3/3), brain (6/7), sperm (0/1)
Imprinted; maternal allele
hypermethylatedc
aTotal number of samples with ASM/number of heterozygous samples tested, including Sanger and 454 long read bis-seq and HpaII pre-digestion/PCR/RFLP assays.
bMaternal allele consistently hypermethylated; ASM restricted to the placenta; biallelic hypomethylation in other tissues examined, including sperm.
cMaternal allele consistently hypermethylated in all somatic tissues examined; biallelic hypomethylation in sperm.
doi:10.1371/journal.pgen.1003622.t001
Figure 2. ASM downstream of the RPN1 gene and in the VTRNA2-1 gene is due to genomic imprinting with hypermethylation of the
maternal allele. Trios consisting of matched parents (PBL) and offspring (placental chorionic villi from the fetal surface) were analyzed for ASM to
determine the parental origin of the hypermethylated and hypomethylated alleles in the C3orf27-RPN1 and VTRNA2-1 index regions. A, HpaII-
predigestion/PCR/RFLP assay for ASM at non-polymorphic HpaII sites in an amplicon including SNP rs12487604 (located immediately downstream of
RPN1) which creates a BtsI restriction site. Undigested genomic DNA and genomic DNA pre-digested with the methylation-sensitive restriction
enzyme HpaII were amplified by PCR and then digested with BtsI. In the samples pre-digested with HpaII (+) one allele drops out, indicating
hypomethylation. A homozygous case for each allele is shown, as well as four heterozygotes; two cases show T-allele hypermethylation and two
show A-allele hypermethylation. B, Trios analyzed by this assay showing parental imprinting of the index region downstream of RPN1. A total of 13
informative trios (two shown) were analyzed and each showed hypermethylation of the maternally-derived allele in the placenta (p,0.00311). C,
Examples of bis-seq of trios for the index amplicon including SNP rs2346019 in the VTRNA2-1 locus. The hypermethylated allele was found to be
maternally derived in each of 10 informative trios (p,0.001565).
doi:10.1371/journal.pgen.1003622.g002
DMRs for Imprinted and Non-Imprinted ASM
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matches that in humans, with the maternal allele relatively
hypermethylated (Figure S5B). The main finding from this analysis
- that the parental imprint is much weaker in mice - suggests that
non-conserved, human-specific, sequences are important for
establishing or stabilizing the methylation imprint in this
chromosomal region.
A well-studied group of growth-regulating genes in fact show
conserved imprinting in the placentas of humans and mice
[10,11], but the poor conservation of imprinting of the RPN1
downstream region is not surprising, as gene regulation in the
placenta is known to be rapidly and continually evolving in
mammals along with changes in placental anatomy [12,13]. Given
that genomic imprinting appears to have evolved in mammals with
placentation, a prediction is that the C3orf27-RPN1 intergenic
DMR, and its associated RNA transcripts, may play a ‘‘human-
specific’’ role in placental growth and development that is not
conserved in mice. Overall, these data add two new loci to the
current list of approximately 80 human genes with robust
methylation imprinting characterized to date.
Discrete DMRs are found both in imprinted domains and
in chromosomal regions with non-imprinted haplotype-
dependent ASM
To compare the structures of chromosomal domains with
imprinted versus non-imprinted ASM we used high throughput
bisulfite PCR (Fluidigm AccessArray) with sample bar-coding,
followed long-read 454 Pyrosequencing of amplicons bracketing 3
of the index regions; two with imprinted ASM (VTRNA2-1 and
C3orf27-RPN1) and one with non-imprinted/haplotype dependent
ASM (STEAP3-C2orf76). To maximize the information from this
approach we designed the amplicons to contain SNPs with
heterozygosities $0.2 and to span DNA segments containing $4
CpG dinucleotides. For VTRNA2-1 region, 6 additional ampli-
cons covering 3 CpGs were included. The long-read sequencing
platform was optimal for analyzing ASM as it allowed us to
capture the CpG methylation pattern and SNP genotype in each
read, with no ambiguity as to phase, while the primer bar-coding
strategy facilitated the analysis of a large series of individuals, with
DNA samples from various tissue types including placenta, PBL,
lung, liver, brain, heart, peripheral blood mononuclear cells
(PBMC) and polymorphonuclear leukocytes (PMN).
The resulting dataset for the 3 chromosomal regions consisted of
104 amplicons analyzed in 96 biological samples, totaling 354 Mb
of bis-seq, with a mean depth of 90 sequences per sample per
amplicon and with a mean read length of 304 bp. Also included
are data from .3500 full-length Sanger bis-seq reads of from 300
to 500 bp, which we carried out on multiple amplicons and tissue
samples to supplement and verify the 454 data. Our strategy
allowed us to score net and allele-specific methylation for each
informative amplicon over multiple CpGs with complete genetic
phase information in each read. The data are summarized by
color-coding for ASM (difference in percent methylation of allele
A versus allele B averaged for heterozygous samples by tissue) in
Figure 3 and Figure 4. These ‘‘ASM heat maps’’ illustrate the
amplicons for each chromosomal region, aligned to UCSC
genome browser tracks [14], showing CpG islands (CGIs), histone
modifications and CTCF binding sites.
The most striking finding from this long-range analysis, and
from additional intensive short-range mapping by Sanger bis-seq
(Figs. 5 and 6A), is the discrete nature of all three DMRs; for all
three regions, two with imprinted ASM and one with non-
imprinted haplotype-dependent ASM, the allelic asymmetry in
DNA methylation is restricted to one or two adjacent amplicons,
with all three DMRs being less than 2 kb in length (Figs. 5 and 6
and Table 1). Within each of the regions examined, the flanking
DNA outside of the DMRs showed varying levels of net CpG
methylation, without asymmetry between the two alleles. Our
mapping does not rule out additional DMRs farther away, but for
the STEAP3-C2orf76 region, which shows haplotype-dependent
ASM, any DMRs farther away would be in separate haplotype
blocks and therefore be independently regulated domains. We
additionally carried out short-range mapping of ASM around the
ELK3 intragenic index fragment, which showed that it too is
discrete and ,2 kb in size (Figure S6).
Both imprinted and non-imprinted DMRs can overlap
precisely with CTCF binding sites
Alignment of our methylation sequencing data with ChIP-Seq
data from ENCODE and related projects, as displayed on the
UCSC genome browser [14], showed that for both of the 2
imprinted domains, and for the non-imprinted STEAP3-C2orf76
intergenic region, though not for the ELK3 intragenic DMR, the
DMRs with ASM overlapped precisely with empirically deter-
mined CTCF binding sites (Figs. 5, 6A and Figure S6). To ask
whether there are additional examples of small discrete DMRs
with strong and recurrent haplotype-dependent ASM that overlap
with CTCF binding sites, we returned to an interesting locus with
haplotype-dependent ASM and ASE that we had characterized in
our initial report on this phenomenon [7], namely, the CYP2* gene
cluster in chromosome band 19q13.2. As shown in Figure 7, the
intragenic DMR in CYP2A7, tagged by SNP rs3815710, in fact
shows discrete borders and precise co-localization with a CTCF
binding site. Another DMR in this large gene cluster, tagged by
SNP rs3844442 and located between 2 CYP2* pseudogenes [7],
overlaps with a weaker CTCF binding site. Maps of each of these
regions with haplotype-dependent ASM are shown aligned to
haplotype blocks in Figure S7.
Methylation-dependent binding of CTCF to the STEAP3-
C2orf76 DMR
To test directly for allele specific binding of CTCF to the
STEAP3-C2orf76 DMR, we carried out CTCF ChiP on a freshly
obtained blood sample from a heterozygous individual that had
shown strong sequence dependent ASM by previous bis-seq. By
comparison with the IgG control IP, end-point PCR amplification
of a region of the STEAP3-C2orf76 DMR covering the index SNP
rs1530562 confirmed CTCF binding to this region, and Sanger
sequencing of the PCR product confirmed that only the
hypomethylated allele was present in the CTCF enriched product,
while both alleles were observed in the PCR product from the
input non-immunoprecipitated DNA (Fig. 6B). Thus, CTCF binds
specifically to the hypomethylated allele of the STEAP3-C2orf76
intergenic DMR.
Analysis of whole genome bis-seq data shows a non-
random association of ASM sites with CTCF site locations
and overlap with GWAS peaks
To test for a possible genome-wide non-random association of
ASM with CTCF sites, we used previously published ASM site lists
[15] from whole genome bis-seq of a single cell line, namely H1
hES cells [16]. Chen et al. [15] found 83,000 CpG sites with ASM,
representing 14% of the total CpGs tested (a high percentage that
partly reflects incomplete filtering-out of CpG SNPs in their
analysis.) Based on their analysis, we first asked whether the ASM
regions that we have described here were also detectable in H1
hES cells. The multi-tissue ASM we identified in the STEAP3-
C2orf76 and VTRNA2-1 index regions was also present in the H1
DMRs for Imprinted and Non-Imprinted ASM
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hES cells, while the tissue-specific ASM found in C3orf27-RPN1
was not present. In addition, the ASM we found in the CYP2A7
region was not mirrored in H1 hES cells, consistent with tissue-
specificity for liver.
We then looked for CTCF binding peaks in 500 bp windows
centered on each of the CpGs tested by Chen et al. for ASM, using
ChIP-seq data generated in H1 hES cells by the Broad/MGH,
Hudson and UT-Austin ENCODE groups. We found 13,485
CTCF binding sites in the vicinity of the informative CpG sites.
Most of these CTCF binding sites were in intragenic or intergenic
regions (47%); fewer were in gene promoter regions (5%) or next
to CGIs (7%). Overall, CTCF sites were far more frequently
associated with unmethylated CpGs than with fully methylated,
partially methylated or ASM CpGs (Figure S8). However, when
considering only CpG sites in gene promoter regions (within 1 kb
upstream and downstream of transcription starting sites), we find a
1.7-fold increase in the percent of ASM CpGs located near CTCF
binding sites (that is, in a 500 bp window centered on the CpGs),
compared to fully methylated CpG sites, but not unmethylated
CpGs or partially methylated CpGs. When considering only the
99 ASM CpGs located in CGI-associated gene promoter regions
(promoter CGIs) 40.4% were near CTCF sites, while less than
Figure 3. Long-range methylation mapping of the two imprinted regions, C3orf27-RPN1 and VTRNA2-1, in 8 types of human tissues,
shows small discrete DMRs.Maps from the UCSC genome browser (top) and ASM heat maps (bottom) derived from long read bis-seq in the gene
regions. In the genome browser map, the index amplicons that provided the starting points for the mapping are in red, and CTCF binding sites, GC
percentage, CGIs and H3K4me1 activating mark intensities are shown. In the heat maps, light grey shading indicates homozygosity in all samples, and
dark grey indicates heterozygosity in one or more sample with no evidence of ASM. Shades of red indicate ASM, with the intensity scale indicating
the absolute value of the difference in fractional methylation of the two alleles from 0.30 to 1. These data are averaged over all heterozygous samples
for a given tissue. The red stippled cells indicate tissues with a greater than 0.30 average difference in fractional methylation of the two alleles but
with only one heterozygous sample or with less than half of the samples showing significant ASM (p#0.05, using the t-test). The grey stippled cell
indicates an amplicon with insufficient read depth (,10). The number of samples subjected to bis-seq for each tissue is indicated in the parentheses.
A, The C3orf27-RPN1 region shows a single discrete epicenter of ASM (DMR) which overlaps with the initial index fragment discovered using MSNP
data. ASM in this domain is only present in placenta. B, The VTRNA2-1 region shows a single discrete epicenter of ASM (DMR) which overlaps with the
initial index fragment discovered using MSNP data. ASM in this domain is present in all 8 tissues. However, ASM with less robust evidence and less
consistency between samples (stippled red cells) was found in several immediate flanking amplicons (amplicons 21, 22, 24, 26).
doi:10.1371/journal.pgen.1003622.g003
Figure 4. Long-range methylation mapping of the non-imprinted STEAP3-C2orf76 region in 8 types of human tissues shows that
small discrete DMRs can be present in loci with non-imprinted ASM. A map from the UCSC genome browser and an ASM heat map derived
from long read bis-seq in the STEAP3-C2orf76 region. In the genome browser map, the index amplicon that provided the starting point for the
mapping is in red, and CTCF binding sites, GC percentage, CGIs and H3K4me1 activating mark intensities are shown. The presence and strength of
ASM is color-coded as in Figure 3. This region shows a single discrete epicenter of ASM (DMR) which overlaps with the initial index fragment
discovered using MSNP data. ASM in this domain is present in 6 tissues. The red stippled cells indicate tissues with a greater than 0.30 average
difference in fractional methylation of the two alleles but with only one heterozygous sample or with less than half of the samples showing significant
ASM (p#0.05, using the t-test). The grey stippled cells indicate amplicons with insufficient read depth (,10).
doi:10.1371/journal.pgen.1003622.g004
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Figure 5. Local mapping of the imprinted C3orf27-RPN1 and VTRNA2-1 DMRs shows precise overlap with CTCF binding sites. A, Bis-
seq of heterozygous placenta samples for amplicons immediately downstream of the RPN1 gene shows ASM localized to a discrete region of about
1 kb in length (chr3: 128,336,485–128,337,414) spanning a strong CTCF binding site and a CGI. Amplicons with ASM are colored red. B, Bis-seq of
heterozygous PBL samples for amplicons surrounding the VTRNA2-1 vault RNA gene shows ASM localized to a 1.9 kb region (chr5: 135,414,670–
135,416,821) spanning one CTCF binding site, two small CGIs, and the VTRNA2-1 RNA gene, while another CTCF binding site upstream is
hypomethylated. ASM for both genes was evaluated visually and by T-tests on the percent methylation of individual clones, comparing the sets of
clones for the two alleles.
doi:10.1371/journal.pgen.1003622.g005
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Figure 6. The STEAP3-C2orf76 DMR with non-imprinted ASM overlaps a CTCF site, with CTCF preferentially bound to the
unmethylated allele, and cross-indexing of ASM-associated CTCF sites with GWAS peaks provides evidence for regulatory
haplotypes. A, Bis-seq of the STEAP3 - C2orf76 intergenic DMR in heterozygous PBL samples shows localization of ASM to a discrete region about
450 bp in length (chr2: 120,048,634–120,049,081) spanning the strong CTCF binding site. *No heterozygous samples were found for rs55740427. B,
PCR of the STEAP3 - C2orf76 intergenic DMR performed on non-immunoprecipitated input DNA, negative control IgG IP DNA and CTCF ChIP DNA. As
expected, the non-immunoprecipitated input sample results in a strong amplification while the negative control IgG IP sample shows no
amplification. The observed amplification in the CTCF immunoprecipitated sample demonstrates CTCF binding at this region. Direct sequencing of
end-point PCR products shows that the non-immunoprecipitated input DNA is heterozygous at the index SNP rs1530562 while the CTCF ChIP sample
shows a strong enrichment for the A-allele indicating that CTCF is bound selectively to this (hypomethylated) allele. C, Maps of 4 representative
haplotype blocks containing both a CTCF binding site with at least two ASM CpG sites (as defined by Chen et al. [15]) within a 1 kb window and SNPs
associated with important human traits or disease susceptibility from GWAS (supra-threshold or strong sub-threshold peaks, all p,1026; http://www.
genome.gov/gwastudies). The relevant traits or diseases are indicated next to each SNP. The CpG sites that were analyzed for ASM (vertical lines) and
located near the CTCF binding sites (horizontal black bars below the lines) are color-coded as orange for ASM sites that do not overlap with a CpG
SNP, green for CpG SNP ASM sites, gray for non ASM sites. See also Table S4.
doi:10.1371/journal.pgen.1003622.g006
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30% of fully methylated and partially methylated and only 23% of
completely unmethylated CpGs in promoter CGIs were near
CTCF sites (Figure S8A). Conversely, the distribution of the
different classes of CpG sites (ASM, fully methylated, partially
methylated, fully unmethylated) with the presence of CTCF
binding sites in a 500 bp window centered on the CpG sites
compared to their distribution without CTCF binding sites in such
windows, reflected this association between ASM and CTCF
binding sites in promoter regions and CGIs, with an increased
proportion of ASM in these regions (Figure S8B).
Next, to more confidently enumerate the CTCF sites overlap-
ping or very close to regions of ASM, we looked specifically for
CTCF binding sites with $2 ASM CpGs (as defined by Chen et
al. [15]) in a 1 kb window centered on the CTCF peak. A total of
158 CTCF sites met this criterion; among them, 142 were gene
associated, with at least one named gene within 100 kb of the
CTCF sites. Of these genes, we were able to cross-tabulate 75 to
the current GWAS catalog (http://www.genome.gov/gwastudies).
Interestingly, 61 of them were associated with a major human trait
or disease susceptibility signal, and for 25 genes the CTCF binding
sites, ASM and the GWAS peak SNP were all located in the same
haplotype block - suggesting that these GWAS signals reflect a bona
fide (functionally active) regulatory haplotype (Table S4, including
our annotations for CpG SNPs, and examples in Fig. 6C). Thus,
while CTCF sites are not enriched overall near regions of ASM,
ASM-associated CTCF sites have a somewhat different distribu-
tion than other CTCF sites and, more importantly, are often
associated with GWAS peaks for human traits and diseases.
Allele-specific expression of some but not all genes near
the imprinted and non-imprinted DMRs
One of the biologically important consequences of ASM is
allele-specific RNA expression (ASE). We previously demonstrated
strong haplotype-dependent ASE of the CYP2A7 gene [7], and we
were interested to ask whether ASE could be detected in the other
chromosomal regions with ASM analyzed in this report. Assays
comparing the representation of SNPs in genomic versus cDNA
PCR products showed a definite and recurrent bias in allele-
specific mRNA expression of the C2orf76 gene, associated with the
STEAP3-C2orf76 DMR (Fig. 8). The untranslated AK097792
RNA transcript, associated with RPN1-C3orf27 DMR also showed
a recurrent bias in ASE: from 13 tested individuals informative for
ASE, 6 showed a definite but not complete allele-specific bias, four
had complete ASE and three were biallelically expressed (Fig. 8
and Fig. S3). In each of 6 informative samples with definite or
complete ASE, and data for ASM, the relatively hypermethylated
allele was the repressed one, suggesting a functional link between
ASE and ASM at this locus. Interestingly, current ENCODE data
support our findings from RT-PCR of a long non-coding RNA
(lncRNA) traversing the DMR, and also suggest that a micro-
RNA, as yet unnamed, arises from very close to this DMR (Figure
S3).
The absence of transcribed SNPs prevented ASE assays for
VTRNA2-1, but as was found by Treppendahl et al. [8] using a
different cell line, our assays for activation of this gene by the
demethylating drug 5aza-dC provided evidence for methylation-
dependent expression of VTRNA2-1 in HL60, ML3, and Jurkat
Figure 7. Local mapping of ASM in the CYP2A7 gene shows a discrete DMR that precisely overlaps a CTCF binding site. Bis-seq of
heterozygous liver samples for multiple CYP2A7 amplicons shows ASM localized to a roughly 400 bp region (chr19: 41,386,227–41,386,613) spanning
a CGI and a CTCF binding site in exon 2. ASM was evaluated visually and by a T-test on the percent methylation of individual clones, comparing the
sets of clones for the two alleles.
doi:10.1371/journal.pgen.1003622.g007
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leukemia cells (Figure S9). Additional analyses showed that the
STEAP3 gene is biallelically expressed in PBL and liver, while
TGFBI and SMAD5, flanking VTRNA2-1, exhibit only a slight
allelic expression bias in PBL, as do RPN1 and C3orf27 in placental
samples (data not shown).
Discussion
ASM is a well-studied hallmark of genomic imprinting.
However, in the past several years this same type of allelic
asymmetry has been found in and around many non-imprinted
genes, both in normal human tissues and in F1 progeny of inter-
strain mouse crosses [1,17]. In contrast to imprinted ASM, in
which the methylation status is dictated by the parent of origin of
the allele, when ASM occurs at non-imprinted loci it is usually
haplotype-dependent. Thus non-imprinted ASM is controlled by
genetic polymorphisms, such as SNPs, indels and copy number
variants (CNVs), which act in cis to set up the allelic asymmetries.
The mechanism(s) by which this occurs are not yet understood.
Research on this topic is important because haplotype-dependent
ASM, with its functional correlate of genotype-specific gene
expression manifesting as ASE and expression quantitative trait
loci (eQTLs), is a major route by which inter-individual genetic
differences in non-coding sequences can lead to differences in
phenotypes, including disease susceptibility.
Here we have described new examples of genes and regulatory
sequences with imprinted and non-imprinted ASM, which have
revealed epigenomic features that are shared between these two
epigenetic phenomena. Genes that are regulated by parental
imprinting frequently have important roles in cell proliferation and
tissue growth, so it is interesting that the VTRNA2-1 gene may
have a suppressor role in human acute myeloid leukemias and
other cancers [8,18], and that vault RNAs are strongly
upregulated during ES cell differentiation [19]. Similarly, given
the clear importance of multiple imprinted genes in placental and
fetal growth [10,11], and the accumulating data for rare but
recurrent alterations of maternal imprints in offspring conceived
by assisted reproductive technologies, the imprinted C3orf27-RPN1
Figure 8. Non-imprinted ASM in the STEAP3-C2orf76 region and imprinted ASM in the RPN1-C3orf27 regions are both associated with
ASE. A, ASE of the C2orf76 gene, associated with the C2orf76-STEAP3 DMR, is shown in duplicate for four PBL samples (rs6542522). In each case the C
allele is preferentially expressed in the cDNA when compared to the genomic DNA, consistent with the sequence dependent nature of ASM in this
locus. Overall, 12 informative PBL samples were analyzed in duplicate for ASE and 7 PBL samples showed preferential expression of the C allele.
Likewise, preferential expression of the C allele was identified in 7 out of the 22 informative liver samples (data not shown). B, ASE of the lncRNA
corresponding to the AK097792 EST, overlapping the index SNP rs2811488 in the RPN1-C3orf27 intergenic DMR are shown on the left and those
overlapping two additional informative SNPs, i.e. rs35604103 and rs61112519, are shown on the right for four placenta samples. Overall, the assays
were performed in duplicates for 13 informative placenta samples. Ten of them showed a definite or complete ASE. In each of 6 informative samples
assayed for both ASE and ASM, the hypermethylated maternal allele was the relatively repressed one.
doi:10.1371/journal.pgen.1003622.g008
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chromosomal domain, including the lncRNA corresponding to the
AK097792 EST, as well as other RNAs, such as the as yet
unnamed micro-RNA precisely localized to this region by data
from the ENCODE/CSH project (Figure S3) will be interesting
for future studies of placental growth and function. The loci with
non-imprinted ASM that we have described here are also
potentially relevant to human traits. CYP2A7 is located immedi-
ately adjacent to and is highly homologous to the CYP2A6 gene,
and both genes are predicted to encode cytochrome P450 proteins
responsible for coumarin and nicotine metabolism and smoking
behavior [20]. The C2orf76 gene encodes a protein with unknown
function, but a non-synonymous SNP in this gene was tentatively
implicated in HIV susceptibility in African-Americans by GWAS
at a nominal p-value of 0.0001 [21]. As we have previously
pointed out [1], a major utility of mapping non-imprinted,
haplotype-dependent ASM is to reveal bona fide regulatory
haplotypes underlying human complex disease susceptibility. In
this regard, our current analysis of prior whole genome bis-seq
data has already yielded an interesting set of additional loci in
which GWAS signals for important human traits and disease
susceptibility coincide with both ASM and CTCF sites.
Lastly, our data lay an essential groundwork for testing
mechanisms of haplotype-dependent ASM. One feasible applica-
tion will be in determining the minimal sequence requirements
that allow local haplotypes to dictate methylation patterns in cis:
based on our mapping data it should be possible to design allelic
series of large bacterial artificial chromosomes (BACs) containing
the chromosomal regions described here, which can be subjected
to targeted site-directed mutagenesis, including the CTCF sites as
well as haplotype-specific sequences outside of these sites, and then




Tissues from human organs were obtained, without patient
identifiers, from the Molecular Pathology Shared Resource of the
Herbert Irving Comprehensive Cancer Center and blood samples
from volunteers were obtained with informed consent under
protocols approved by the internal review board of Columbia
University Medical Center. MSNP assays were performed as
previously described [7]. Affymetrix 250K StyI and 6.0 SNP arrays
were used, with initial complete digestions of the genomic DNA
samples with StyI (250K arrays) or NspI (6.0 arrays), with the
methylation-sensitive restriction enzyme HpaII or with its meth-
ylation-insensitive isoschizomer MspI, followed by probe synthesis
and labeling as recommended by Affymetrix. The MSNP data
were processed numerically as described [7], followed by
visualization of the allele-specific hybridization data in dChip
[22] to identify SNP-tagged StyI or NspI restriction fragments
where call conversions were made from AB with no HpaII to AA
or BB with HpaII pre-digestion. Based on recurrent call
conversions in two or more samples and consistency of hybrid-
ization across multiple probes on visualization of the intensity data,
we selected loci for validation of ASM by bis-seq of amplicons
spanning the original index SNPs.
Local methylation mapping by Sanger bis-seq
We used Sanger bis-seq of multiple clones for intensive short-
range mapping of ASM in each of the 5 chromosomal regions, as
well as for filling gaps in the long-read 454 bis-seq. Genomic DNA
(0.5 mg) was bisulfite converted using the EpiTect Kit (Qiagen)
following the manufacturer’s protocol. Primers were designed in
MethPrimer [23] to encompass .5 contiguous CpGs and one or
more SNP, and the converted DNA was amplified for regions of
interest using optimized PCR conditions (Table S1). PCR
reactions were performed in duplicate then pooled and purified
using the Wizard SV System (Promega), followed by cloning using
the TOPO TA Kit (Invitrogen). Multiple clones were sequenced.
Extended methylation mapping by Fluidigm bisulfite PCR
and 454 long-read sequencing
Primer sets spanning 50–100 kb on each side of each of the
three index fragments for long-range mapping were designed as
described in [24] and in part empirically, using both strands of an
in silico bisulfite-converted SNP-masked genome. Primer sequences
were not allowed to overlap with any SNPs having .1 percent
heterozygote frequency in dbSNP130. Amplicons were allowed to
range between 200–650 bp in size, with most between 200–
450 bp. CpG content was allowed to range between 0–1 CpGs per
primer with zero CpGs preferred. Tm was allowed to range from
56–60uC, primer GC content is allowed to range between 35–
65%, and self-complementarity, primer-primer complementarity,
and hairpin formation is restricted for stable structures with
melting temperatures above 46uC. Primers generating off target
amplicons of size 50–2000 bp (with two mismatches allowed) were
filtered out by scanning against a bisulfite converted genome with
NCBI reverse e-PCR. From these primer sets, 41 amplicons for
the VTRNA2-1 region, 27 amplicons for the STEAP3-C2orf76
region and 25 amplicons for the C3orf27-RPN1 region were picked
based on minimum cut-offs for the number of CpG sites
encompassed in each amplicon ($4), and heterozygosity frequen-
cies of annotated SNPs between the primers ($.2). For VTRNA2-
1 region, 6 additional amplicons covering 3 CpGs were included.
Primer sequences are in Table S2. Bisulfite modification was
performed for 96 samples using 2 ug of genomic DNA and the
Epitect 96 Kit (Qiagen), following the recommended protocol.
The bisulfite modified DNA was re-precipitated and concentrated
using Pellet Paint (EMD Chemicals). To amplify the DNA from
the 96 samples, the Fluidigm 48648 Access Array was used, with
JumpStart Taq Polymerase (Sigma) and a 60uC touchdown for ten
cycles followed by 51uC for 29 cycles of amplification. Of the
resulting PCR products, one microliter of a 1:50 dilution was used
in a second barcoding PCR reaction. Fluidigm barcodes designed
with 454 adapters were added to samples 1–48 and 49–96 during
this PCR step. Both the 454 FLX instrument and 454Junior
instrument and their emPCR and Sequencing kits (Roche) were
used. The barcoded PCR products were pooled and purified using
Agencourt AMPure XP beads and a titration was performed
(described in 454 provided protocol) in order to find the best
bead:DNA ratio required to remove DNA fragments smaller than
300 bp. The purified PCR products were then prepared for
sequencing following the 454 emulsion PCR protocol (Roche). A
titration of bead:DNA ratios was also performed during this step to
ensure an ideal ratio was achieved in order to obtain the best
sequencing results. The amplified PCR products were then
sequenced using the sequencing kits designed for each instrument.
The filter settings were adjusted on the 454 sequence analysis
software to a vfTrimBack Scale Factor of .5. The sequences were
then mapped, scored for each previously identified SNP, and each
allele was analyzed for percent methylation, both at individual
CpGs and averaged over all CpGs in the amplicon. Of the original
99 primer pairs, 91 gave a sufficient number of reads to allow
genotyping (minimum ten reads with at least 20% of reads
representing the minor allele), and net methylation analysis in
most samples, and in at least 3 samples per tissue (minimum 7
reads), as well as scoring ASM in multiple heterozygous samples.
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Also included were data from .3500 full-length Sanger bis-seq
reads of from 300 to 500 bp performed on several amplicons and
tissues. T-tests were performed to determine significant ASM,
p,0.05, for samples with at least 5 reads per allele.
Q-PCR and analysis of allele specific mRNA expression
(ASE)
Tissue and blood cell RNA was extracted using Trizol
reagent (Invitrogen) following the manufacturer’s protocol. The
RNA was then reverse transcribed to cDNA using RT Kit
(AmbionRETROscript) with random hexamer primers. PCR
primers were designed for genomic DNA and cDNA to cover a
SNP in the exon of the gene of interest using Primer3 software,
with the cDNA primers spanning an intron of the gene, or in
the case of the AK097792 non-translated RNA, not spanning
an intron but verified as amplifying only cDNA in the samples
tested, by lack of PCR product in the minus-RT control
reaction (Table S3). Genomic DNA and cDNA were amplified
by PCR and the PCR products were Sanger sequenced from
duplicate reactions. The sequence chromatograms were ana-
lyzed by comparing peak heights of the two alleles in
heterozygous individuals in the genomic DNA versus cDNA.
For measuring expression of the VTRNA2-1 small RNA we
used a custom TaqMan assay (Applied Biosystems) according
to the recommended protocol.
Chromatin immunoprecipitation (ChIP)
Peripheral blood mononuclear cells (PBMCs) were isolated from
whole blood following the manufacturer’s instructions for
FicollPaque Plus reagent (GE). Chromatin Immunoprecipitation
was performed on the PBMCs using the Magna-ChIP G Kit from
Millipore following the suggested protocol with some slight
modifications. Cell fixation was performed for six minutes.
Sonication was performed using a Fisher Sonic Dismembrator at
a power setting of 3.2 for 2 minutes total sonication time with
2 seconds sonication followed by 8 seconds recovery. Four
micrograms of anti-CTCF antibody (Millipore) was used in an
overnight incubation at 4uC with sheared chromatin and protein
G Magna ChIP beads. PCR for the STEAP3-C2orf76 DMR was
then performed using primers: Forward, GACAGACTCT-
GCTGCCACCT and Reverse, AGCAGCTTCTTCTCGG-
TATG. Two microliters of purified input, negative control IgG
and CTCF immunoprecipitated samples were used for PCR with
a touchdown from 60uC to 51uC for 38 cycles.
Analysis of genome-wide association of ASM with CTCF
binding sites
Previously published ASM site lists from the whole genome
bis-seq of H1 hESC cells were downloaded [15,16]. The dataset
included 514,181 CpG sites tested for ASM by Chen et al. [15].
Of these, 79,365 were CpG sites classified as ASM. For this
analysis, in addition to ASM sites, we grouped CpG sites
without evidence of ASM into 3 categories: full methylation
(200,318 CpG sites with .90% of reads with methylation at the
CpG site), partial methylation (232,724 CpG sites with 10% to
90% of reads with methylation at the CpG site) or complete lack
of methylation (1,774 CpG sites with ,10% of reads with
methylation at the CpG site). To assess the presence of CTCF
binding peaks in a 500 base window centered on each CG tested
for ASM, we used ChIP-seq data generated in H1 hESC cells by
the Broad/MGH (UCSC accession number: wgEnco-
deEH000085), Hudson alpha (UCSC accession number:
wgEncodeEH001649) and UT-Austin (UCSC accession num-
ber: wgEncodeEH000560) ENCODE groups. We searched for
CTCF binding sites present in at least one of these datasets and
found 13,485 CTCF binding sites in the vicinity of the CpG
sites included into this analysis. We performed sub-analyses in
order to look specifically at CpG sites in intergenic regions or
intragenic region, as well as in gene promoter regions (1 kb
upstream and downstream of transcription starting sites of
genes) and/or close to CGIs (within 250 bp), using data
available from the UCSC genome browser. All p-values for
these analyses were calculated using one-sided Fischer exact
tests.
Supporting Information
Figure S1 Primary MSNP data for the index regions in this
study. MSNP data (allele-specific hybridization intensities from
Affymetrix SNP 250K StyI and SNP 6.0 arrays) were processed
in dChip as in Kerkel et al., 2008. For each of the index regions
shown, the heterozygous SNP call changes to a ‘‘homozygous’’
call when the genomic samples are digested with the
methylation-sensitive restriction enzyme HpaII prior to probe
synthesis. The index amplicons for verifying ASM are indicated
by the grey rectangles below the maps; CG-islands (CGIs) are
indicated by green rectangles. A, Primary MSNP data for the
ELK3 index region. B, Primary MSNP data for the C3orf27-
RPN1 index region. C, Primary MSNP data for the VTRNA2-1
index region. D, Primary MSNP data for the STEAP3-C2orf76
index region. The index region between STEAP3 and C2orf76
was identified initially using an acute myeloid leukemia (AML)
sample, but was then validated by pre-digestion/PCR and bis-
seq data as showing ASM in numerous normal human tissue
samples.
(TIFF)
Figure S2 Examples of additional biological samples with non-
imprinted haplotype-dependent ASM in the STEAP3-C2orf76
intergenic region. The ASM is strongest in PBL and acute myeloid
leukemia cases (AML). There is variable ASM in the liver samples
and weaker ASM in the HMEC samples. In all cases the G-allele is
relatively hypermethylated.
(TIFF)
Figure S3 Bisulfite sequencing of heterozygous and homozygous
samples in the imprinted index region immediately downstream of
the RPN1 gene. LncRNA mapping in C3orf27-RPN1. A,
Homozygous and heterozygous placenta, sperm and human
mammary epithelial cell (HMEC) samples are shown. The two
homozygous placentas (upper-left panel) show a biphasic methyl-
ation pattern consistent with imprinting. The four heterozygous
placental samples show strong ASM with the G allele or A allele
hypermethylated, also consistent with imprinting (upper-right and
middle panel). The parent-of-origin dependence of the ASM, that
is, proof of imprinting, is shown in Figure 2 of the main text. No
methylation is seen in the HMEC and sperm samples (lower
panel). B, LncRNA in C3orf27-RPN1 region. We used RT-PCR of
DNAse-treated placental RNA samples to map a minimum region
over which the lncRNA is detectable. The black solid lines show
the position of the amplicons used and the lncRNA transcript is
indicating with (+) on the top of the amplicons. A graphical
representation, based on the available data from the USCS
genome browser, for human ESTs, long RNA-seq and small
RNA-seq is shown below the map.
(TIFF)
Figure S4 Examples of additional biological samples with ASM
in the imprinted VTRNA2-1 gene. Strong ASM is seen in lung,
DMRs for Imprinted and Non-Imprinted ASM
PLOS Genetics | www.plosgenetics.org 13 August 2013 | Volume 9 | Issue 8 | e1003622
HMEC and liver samples, while the sperm samples are
unmethylated.
(TIFF)
Figure S5 CpG methylation patterns in the mouse C3orf27-
Rpn1 region are determined by a cis-acting haplotype effect
superimposed on weak parental imprinting. A, Map of the
region of the mouse genome that is orthologous to the human
C3orf27-RPN1 region and bisulfite sequencing of the Rpn1
downstream region. There is only partial conservation of
synteny. Primers used for bisulfite PCR were GGGTTAAGG-
GATTGTTTAAATAGTTA and ACCAAACCTTTAAAC-
CAAAAAAAAC, which amplify a 390 bp CG-rich sequence
that does not meet formal criteria for a CGI. B, Percent
methylation of each allele as a function of strain-of-origin and
parent-of-origin. T-tests were performed on the dataset
consisting of the methylation values for each of the allele-
specific bisulfite clones in each of the indicated yolk sac samples
with known strain- and parent-of-origin.
(TIFF)
Figure S6 Local methylation mapping of the ELK3 DMR.
Bisulfite sequencing of heterozygous PBL samples for multiple
ELK3 amplicons shows the specific range of sequence dependent
ASM in this locus, spanning 225 bp (chr12: 96,617,249–
96,617,474).
(TIFF)
Figure S7 Haplotype blocks aligned to the loci with non-
imprinted sequence dependent ASM using International HapMap
Project (http://hapmap.ncbi.nlm.nih.gov/). In the gene maps the
grey bars indicate the index DMRs, green bars indicate CGIs, blue
bars are CTCF sites and the black rectangles are gene exons. Each
of the DMRs is within a block of strong linkage disequilibrium.
The STEAP3-C2orf76 DMR (A) and the CYP2A7 DMR (C)
overlap CTCF binding sites, while the ELK3 DMR (B) , which has
recurrent but less strong ASM, does not.
(TIFF)
Figure S8 Association of ASM CpGs with particular locations
of CTCF binding sites in H1-hESC. A, Bar graphs and table
showing the percentage of the different classes of CpG sites in or
near CTCF binding sites (in 500 bp windows centered on the
CpG sites analyzed by Chen et al. [15]) in H1-ES cells. Classes
of CpG sites (ASM as determined by Chen et al. [15], or fully,
partially, or unmethylated, as determined by us) are color
coded. Separate analyses have been performed for CpG sites in
intergenic regions, intragenic regions, promoter regions, CGIs
and promoter CGIs. The total numbers of sites and one sided
Fischer exact p-values for the enrichment of CTCF sites,
compared to CpGs that are fully methylated, partially
methylated or fully unmethylated, are indicated in the table.
B, Bar graphs showing the distribution of the different classes of
CpG sites (ASM, fully methylated, partially methylated, fully
unmethylated), with or without a CTCF binding site in a 500 bp
window centered on the CpG. The same color codes as in panel
A are used for ASM, fully methylated, partially methylated and
fully unmethylated CpG sites. Separate analyses have been
performed for CpG sites in intergenic regions, intragenic
regions, promoter regions, CGIs and promoter CGIs.
(TIFF)
Figure S9 Effects of the demethylating drug 5aza-dC on
expression of VTRNA2-1 RNA in HL60, ML3 and Jurkat cell
lines. In each cell line, cells were treated with the indicated
concentrations for three days. Increased expression of VTRNA2 is
observed in all three cell lines and a reduction in methylation was
confirmed in Jurkat cells for the index region DMR (data not
shown).
(TIFF)
Table S1 PCR primers for local mapping of ASM by Sanger bis-
seq.
(XLSX)
Table S2 PCR primers for regional mapping by Fluidigm
bisulfite PCR followed by 454 sequencing.
(XLSX)
Table S3 PCR primers for assessing ASE by cDNA/gDNA
sequencing.
(XLSX)
Table S4 Loci with ASM CpGs (.2) near CTCF sites: cross-
tabulated to GWAS peaks. This table is from our analysis of the
original whole genome bis-seq data of Lister et al. (2009) Human
DNA methylomes at base resolution show widespread epigenomic
differences( Nature 462: 315–322), as interpreted for ASM by
Chen et al. (2011, A comparative analysis of DNA methylation
across human embryonic stem cell lines. Genome Biol 12: R62.).
(XLSX)
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